Precision BioSciences, Inc. — Cash Flow Charts
8 quarters of history · ending 2025-12-31 · SEC EDGAR
Source:10-K · 10-Q
Capital Allocation
How management deploys cash: investing in the business (Capex + M&A) vs returning to shareholders (Buybacks + Dividends).
Capital Allocation Waterfall
Buybacks vs Stock-Based Comp
Cash Flow
Cash Flow by Activity
Operating Cash Flow↓-0.4% -$71K
$-19M
Free Cash Flow↑+80.4% +$78K
$-19K
Investing Cash Flow
$17K
Financing Cash Flow↑+1209.4% +$72M
$78M
Capex↓-80.4% -$78K
$19K
Stock-Based Comp↓-42.8% -$2M
$2M
D&A↓-24.0% -$109K
$345K
SBC Allocated Expense↓-42.8% -$2M
$2M
SBC Unrecognized Cost
$10M